kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the BRNS dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for BRNS.

BRNS

Barinthus Biotherapeutics plc.
Healthcare · Biotechnology
$155.87 sample
-0.68 (-0.43%) 1D
☆ Watch
Market cap
$630.1B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-01
Alerts
8
Price$155.87 +21.58% 3M daily closessample
156.55128.20
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 19INSInsider buy: Chief Financial Officer
  • Oct 14INSInsider sell: EVP, Operations
  • Oct 09INSInsider buy: 10% owner
  • Oct 01SEC10-Q filed
  • Sep 28INSInsider sell: Director
  • Sep 22INSInsider buy: EVP, Operations
  • Sep 16INSInsider sell: General Counsel
  • Sep 09INSInsider sell: General Counsel
Sign up to see the real BRNS record →

Company facts

SEC EDGAR registration
Name
Barinthus Biotherapeutics plc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
-36sample, -100 to +100
Reporting currency
USD

Who is positioning in BRNS

sample
Insiders
10 insider transactions over 90 days, net selling, $205.0M
Congress
No member trades over 90 days
Institutions · 13F
40 funds hold $5.1B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$15.2B +17.6% y/y
Q4 2024Q3 2026
Inventory$9.4B +16.7% y/y
Q4 2024Q3 2026
Accounts receivable$7.0B +10.5% y/y
Q4 2024Q3 2026
Total debt$19.3B +10.6% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$111.7B +12.3% 3M
Sample peer B
$358.2B +11.6% 3M
Sample peer C
$487.5B +15.6% 3M
Sample peer D
$317.5B +0.5% 3M
Sample peer E
$550.9B -0.1% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not BRNS's real figure. Nothing here is investment advice.